Test Price
2,700 AED✅ Home Collection Available
HLA Pre-Transplant Workup Panel 2 in UAE | 2700 AED | 2026 DHA Guidelines
تحليل HLA قبل الزرع (اللوحة 2) في الإمارات | 2700 درهم | معتمد من هيئة الصحة بدبي
يُعد فحص التوافق النسيجي المتقدم (اللوحة 2) أساسياً لتقييم التطابق بين المتبرع والمتلقي قبل زراعة الأعضاء الصلبة، مع ضمان دقة تصل إلى 99.9% وامتثال كامل لمعايير وزارة الصحة ووقاية المجتمع وهيئة الصحة بدبي لعام 2026.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Certified Processing (ISO 9001:2015) and state-of-the-art Luminex & Flow Cytometry platforms.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
- Insurance: Direct Billing Verification & Pre-Approval via WhatsApp +971 54 548 8731.
Overview
The HLA Pre-Transplant Workup Panel 2 is a comprehensive immunogenetic assessment for solid organ transplant candidates and living donors. It combines high-resolution antibody screening, crossmatching, and serologic/ molecular typing to precisely evaluate histocompatibility and minimize graft rejection risk. (لوحة فحص التوافق النسيجي قبل الزرع – مجموعة متكاملة)
| Feature | Our Test (Panel 2) | Closest Alternative |
|---|---|---|
| Precision | 99.9% Sensitivity via CDC+Flow Crossmatch & Luminex SSOP | ~95% with non-DTT CDC only |
| Methodology | DTT-treated CDC, Reverse SSOP (Luminex X-Map), Flow Cytometry | Basic CDC or single-platform flow |
| Turnaround | 10-12 days (optimized workflow) | Often 15-20 days |
Physician Insight & Safety Protocol
Note from Dr. PRABHAKAR REDDY (DHA: 61713011): This panel provides a critical immunological risk profile, but results must always be interpreted within the complete clinical context. Even a negative crossmatch does not guarantee the absence of late rejection, so lifelong immunosuppression and regular monitoring remain essential. Please schedule a post-test consultation to review the antibody specificities and clinical implications.
⚠️ Medication Warning: Do not discontinue prescribed immunosuppressive or other medications without consulting your transplant physician. Any changes to your regimen may influence crossmatch results or stability.
Safety Exclusion Criteria & Emergency Red Flags
- Active systemic infection or sepsis at time of collection (relative exclusion).
- Inability to provide a valid physician’s prescription with stamped photographs.
- Refusal to sign the mandatory informed consent (Form 33) for solid organ HLA typing.
- Red Flags: If you experience productive cough, fever >38°C, or worsening organ-specific symptoms, immediately contact your transplant coordinator or go to the emergency room.
Pre- Requirements
Sample Collection: DONOR: 12 mL whole blood in 2 Yellow Top (ACD) tubes, 4 mL in 1 Lavender Top (EDTA) tube, AND 4 mL in 1 Green Top (Sodium Heparin) tube. Ship at 18-22°C. DO NOT REFRIGERATE OR FREEZE.
Documentation: Doctor’s prescription on official letterhead with 1 photograph each of recipient and donor duly stamped. Completed and signed Consent Form for HLA Typing for Solid Organ Transplant (Form 33) is mandatory.
Drug/Supplement Avoidance: Disclose all immunosuppressants, biologics, and recent transfusions. However, never stop prescribed drugs without explicit medical instruction.
Patient FAQ & Clinical Guidance
1. Why is the HLA Pre-Transplant Panel 2 critical before transplant?
Direct Answer: This panel detects donor-specific antibodies and crossmatch positivity with 99.9% sensitivity, identifying immunological barriers that could cause hyperacute or acute rejection and guiding donor selection or desensitization protocols.
يكتشف هذا الفحص الأجسام المضادة الخاصة بالمتبرع وتفاعل التوافق الخلطي بدقة 99.9%، مما يحدد العوائق المناعية التي قد تؤدي إلى رفض حاد مفرط أو رفض حاد، ويوجه اختيار المتبرع أو بروتوكولات إزالة التحسس.
2. How should we prepare for the home blood collection service?
Direct Answer: Ensure the donor and recipient avoid heavy exercise 24 hours before collection, have all signed documents ready, and inform the phlebotomist of any recent IVIG or biologic therapies that may interfere with assays.
تأكد من تجنب المتبرع والمتلقي التمارين الشاقة قبل 24 ساعة، وتجهيز جميع المستندات الموقعة، وإبلاغ فني السحب عن أي علاجات حديثة بـ IVIG أو أدوية بيولوجية قد تؤثر على دقة النتائج.
3. What do the results ‘positive crossmatch’ or ‘DSA positive’ mean for the transplant timeline?
Direct Answer: A positive CDC or flow crossmatch, or presence of donor-specific antibodies, indicates a high risk of immediate graft loss; your nephrologist may recommend alternative donor selection, plasmapheresis, or intensified immunosuppression before proceeding.
تعني نتيجة الإختبار الإيجابي للتوافق الخلطي أو وجود أجسام مضادة خاصة بالمتبرع خطورة عالية لفقدان الطعم فوراً؛ وقد يوصي طبيب الكلى باختيار متبرع بديل، أو فصل البلازما، أو تكثيف كبت المناعة قبل الزرع.
Legal Compliance: This service adheres to Federal Decree-Law No. 41 of 2024 (Article 87), the UAE CDS Law 2026 (Minors), and the UAE PDPL (Data Privacy). All clinical activities are performed under DHA Facility License 9834453 and ISO 9001:2015 Certification (Cert: INT/EGQ/2509DA/3139).
Support: Call or WhatsApp +971 54 548 8731 for booking, insurance verification, or urgent medical questions.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians